After the publication of the original article [1] in BMC Psychiatry it was brought to our attention that Figs. 3, 4, 5, 6, 7, 8 and 9 were ordered incorrectly. Please find the correct order of the figures and citations below.
Fig. 3.
The effect of risperidone and aripiprazole on challenging behaviour in children with intellectual disabilities
Fig. 4.
The effect of aripiprazole and risperidone on weight and prolactin levels in children with intellectual disabilities and challenging behaviour
Fig. 5.
The effect of aripiprazole and risperidone on sedation in children with intellectual disabilities and challenging behaviour
Fig. 6.
The effect of valproate and topiramate (added to risperidone) on challenging behaviour in children with intellectual disabilities
Fig. 7.
The effect of valproate and topiramate (added to risperidone) on weight in children with intellectual disabilities and challenging behaviour
Fig. 8.
The effect of valproate and topiramate (added to risperidone) on sedation in children with intellectual disabilities and challenging behaviour
Fig. 9.
The effect of N-acetylcysteine on challenging behaviour in children with intellectual disabilities
Footnotes
The online version of the original article can be found under doi:10.1186/s12888-015-0688-2.
Reference
- 1.McQuire C, Hassiotis A, Harrison B, Pilling S. Pharmacological interventions for challenging behaviour in children with intellectual disabilities: a systematic review and meta-analysis. BMC Psychiatry. 2015;15:303. doi: 10.1186/s12888-015-0688-2. [DOI] [PMC free article] [PubMed] [Google Scholar]